Clinical trials for HER-2 positive breast cancer

 

Trial name

 

Title of clinical trial

 

Hyperlink

 

HER2CLIMB

 

A study testing the effects of Tucatinib in combination with standard treatments in patients with locally advanced or metastatic HER2+ breast cancer.
Open to men & women.

 

Clinical Trials Information

 

Roche BP29842 (FAP)

 

A study evaluating safety, pharmacokinetics, and therapeutic activity of RO6874281 in participants with advanced and/or metastatic solid tumors.
Open to men & women.

 

Clinical Trials Information

 

CORE

 

A randomised controlled trial, which includes breast, prostate or non-small cell lung primary cancer and extra cranial oligometastases suitable for stereotactic body radiotherapy.

 

Clinical Trials Information

 

B-AHEAD 3

 

A randomised trial of intermittent energy restriction and resistance exercise in women receiving chemotherapy for advanced breast cancer.
Open to women.

 

Clinical Trials Information

 

PIPA

 

A study looking at taselisib and palbociclib for breast cancer with a mutation in the PIK3CA gene that has stopped responding to treatment.
Open to men & women.

 

Clinical Trials Information

 

Plasma Match

 

A trial carrying out plasma based molecular profiling of advanced breast cancer to inform therapeutic choices.
Open to women.

 

Clinical Trials Information